Full Breakdown
FDA Proposes First Major Update to Infant Formula Nutrient Standards in Nearly Three Decades
By Drooid · · How we work
In this breakdown
01
Updated Nutrient Requirements
On October 29, the Food and Drug Administration (FDA) issued a proposed rule to revise minimum and maximum levels of iodine, manganese, vitamin A, and vitamin D in infant formula. The agency also seeks comment on making three non-required ingredients—arachidonic acid (ARA), docosahexaenoic acid (DHA) and L-carnitine—mandatory, citing evidence of their role in neurodevelopment.
02
Background and Context
The rule is the first comprehensive review of infant-formula nutrition since 1998 and the initial phase of a three-phase effort announced under HHS’s “Operation Stork Speed” initiative, which expanded testing for heavy metals after recent recalls and infant botulism cases.
Visual evidence
Images from the story
03
Data and Statistics
- Vitamin D – Minimum would double from 1 µg to 2 µg per 100 kcal; maximum would rise from 2.5 µg to 3 µg.
- Iodine – Minimum would increase three-fold from 5 µg to 15 µg, while the ceiling would drop from 75 µg to 50 µg.
- Manganese – Introduces an upper limit of 50 µg per 100 kcal; the minimum would be lowered from 5 µg to 1 µg.
- Vitamin A – Range would narrow to 70–120 µg, down from the current 75–225 µg.
- Cost impact – Reuters reports FDA estimates annual compliance costs for manufacturers between $8.4 million and $31.7 million, with a primary estimate of $17 million.
04
Official Statements & Responses
HHS Secretary Robert F. (text truncated for brevity) and the FDA reiterated that current formulas remain safe and that no immediate changes to the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) are anticipated.
05
Verbatim Quotes
- “We're also requesting public input on ingredients that are not currently required in infant formula, but are commonly added by manufacturers and are actually required in some other countries,” — Kyle Diamantas, acting FDA commissioner
- “There's evidence that these nutrients contribute to neurodevelopment, health and infancy, and we want to hear from the scientific community, from clinicians, from industry and the public as we consider whether or not to make these nutrients mandatory in the U.S. infant formula supply,” — Kyle Diamantas, acting FDA commissioner
06
Timeline
- October 29 – FDA releases the proposed rule and contaminant testing results.
- Late February 2027 – Comment period closes; the agency will accept public input through regulations.gov.
- 60 days after final rule publication – Proposed start date for the rule’s legal effect.
- Three years after effective date – Manufacturers would have a compliance window to reformulate and relabel products.
07
What’s Next
The FDA will consolidate the three phases into a single final rule after reviewing comments. Phase 2, addressing additional vitamins and minerals, is slated for release within the next year; Phase 3 will examine protein, fat, iron, calcium and the optional ingredients ARA and DHA. Once the final rule is issued, manufacturers must submit revised formulations and labeling within the three-year compliance period. The agency will continue contaminant monitoring and maintain its public dashboard for transparency.